The stringent regulation of cell cycle progression helps to maintain genetic stability in cells. MicroRNAs (miRNAs) are critical regulators of gene expression in diverse cellular pathways, including developmental patterning, hematopoietic differentiation and antiviral defense. Here, we show that two c-Myc-regulated miRNAs, miR-17 and miR-20a, govern the transition through G1 in normal diploid human cells. Inhibition of these miRNAs leads to a G1 checkpoint due to an accumulation of DNA double-strand breaks, resulting from premature temporal accumulation of the E2F1 transcription factor. Surprisingly, gross changes in E2F1 levels were not required to initiate the DNA damage response and checkpoint, as these responses could occur with a less than twofold change in E2F1 protein levels. Instead, our findings indicate that the precise timing of E2F1 expression dictates S-phase entry and that accurate timing of E2F1 accumulation requires converging signals from the Rb/E2F pathway and the c-Myc-regulated miR-17 and miR-20a miRNAs to circumvent a G1 checkpoint arising from the untimely accumulation of E2F1. These data provide a mechanistic view of miRNA-based regulation of E2F1 in the context of the emerging model that miRNAs coordinate the timing of cell cycle progression.
The stringent regulation of cell cycle progression helps to maintain genetic stability in cells. MicroRNAs (miRNAs) are critical regulators of gene expression in diverse cellular pathways, including developmental patterning, hematopoietic differentiation and antiviral defense. Here, we show that two c-Myc-regulated miRNAs, miR-17 and miR-20a, govern the transition through G1 in normal diploid human cells. Inhibition of these miRNAs leads to a G1 checkpoint due to an accumulation of DNA double-strand breaks, resulting from premature temporal accumulation of the E2F1 transcription factor. Surprisingly, gross changes in E2F1 levels were not required to initiate the DNA damage response and checkpoint, as these responses could occur with a less than twofold change in E2F1 protein levels. Instead, our findings indicate that the precise timing of E2F1 expression dictates S-phase entry and that accurate timing of E2F1 accumulation requires converging signals from the Rb/E2F pathway and the c-Myc-regulated miR-17 and miR-20a miRNAs to circumvent a G1 checkpoint arising from the untimely accumulation of E2F1. These data provide a mechanistic view of miRNA-based regulation of E2F1 in the context of the emerging model that miRNAs coordinate the timing of cell cycle progression. Oncogene (2009) 28, 140-145; doi:10.1038 /onc.2008 published online 6 October 2008 Keywords: checkpoint; DNA damage; E2F1; miRNA Strictly monitoring cell cycle progression is essential for maintaining genetic integrity in cells. One critical regulatory step in G1, the restriction point (R), commits cells to undergo replication. Major events associated with R include hyperphosphorylation of the retinoblastoma (Rb) protein and derepression of the E2F transcription factors (Dimova and Dyson, 2005) . E2F1, E2F2 and E2F3a act as transcriptional activators on promoters of gene products required for DNA replication, such as DNA polymerase-a and thymidine kinase (DeGregori et al., 1995) . These proteins are required for G1-to S-phase progression as shown by the observation that mouse embryo fibroblasts deleted for all three genes are defective in S-phase entry (Wu et al., 2001) . Genetic stability of cells is also maintained by checkpoints, which halt cell cycle progression following an encountered stressor, such as DNA damage. Data have shown that inappropriate oncogene activation leads to checkpoint activation by signaling a DNA damage response (DDR) (Halazonetis et al., 2008) . Accordingly, Rb inactivation or ectopic expression of one of the activator E2F proteins, E2F1, activates a G1 checkpoint (Lomazzi et al., 2002; Frame et al., 2006) by generating a DDR (Powers et al., 2004; Rogoff et al., 2004; Bartkova et al., 2005; Pickering and Kowalik, 2006; Hong et al., 2008) .
Rb-regulated growth control is crucial in controlling cell proliferation, which may explain why it is disrupted in most, if not all, solid tumors. Emerging data indicate that misexpressed microRNAs (miRNAs) can promote cancer progression by functioning as tumor suppressors or oncogenes (Calin and Croce, 2006) . One commonly overexpressed miRNA cluster is the miR-17-92 cluster, which encodes six mature miRNAs (Mendell, 2008) , and is directly transactivated by c-Myc, a transcription factor that accumulates early in G1 (O'Donnell et al., 2005) . Although the timing of miR-17-92 expression suggests that miRNAs generated from this cluster may function in G1, the physiological role of these miRNAs in G1 is unclear.
Given that c-Myc accumulates early in G1 and is then degraded as cells pass through R (Persson et al., 1985; Rabbitts et al., 1985) and that expression of miR-17-92 temporally correlates with c-Myc expression (O'Donnell et al., 2005) , we determined whether two mature miRNAs derived from that cluster, miR-17 and miR20a, play physiological roles in G1 cell cycle progression. Serum-starved normal human fibroblasts were transfected with 2 0 -O-methyl oligonucleotides complementary to either miRNA sequence (2 0 oMe-miR17; 2 0 oMe-miR20a) (O'Donnell et al., 2005) or a control 2 0 -O-methyl oligonucleotide (2 0 oMe-Luc) (Hutvagner et al., 2004) . Following transfection, growth medium containing serum and BrdU was added to cells, and BrdU incorporation was used to measure the ability of the cells to progress from G1 to S phase. While the BrdU-positive population of untransfected (denoted as 10%) or 2 0 oMe-Luc-transfected cells increased over time, inhibition of miR-17 or miR-20a resulted in reduced levels of BrdU incorporation, similar to the RNA complex reaction, serum-starved cells were trypsinized and soybean trypsin inhibitor was added to inactivate the trypsin. Cells were pelleted and resuspended in Dulbecco's modified Eagle's medium containing 0.1% fetal bovine serum. The transfection complex was mixed with cells and plated. After 6 h, transfection media was replaced with medium containing BrdU until the indicated time points. Protein depletion by siRNA transfection is quantified using Multianalyst software (BioRad, Hercules, CA, USA) of immunoblot analysis. miR17 and miR20a prevent E2F1-induced G1 arrest MT Pickering et al levels seen in control cells maintained in medium with reduced serum (Figure 1a ; 0.1%). These results suggest that miR-17 and miR-20a regulate the G1 to S-phase transition of the cell cycle.
We then asked whether the reduction in BrdU incorporation upon miR-17 or miR-20a inhibition was due to activation of a G1 checkpoint. To ask this question, we depleted cells of key mediators of G1 arrest (Frame et al., 2006) and assessed whether cell cycle progression was still impeded by inhibition of miR-17 or miR-20a. Inhibiting the miRNAs resulted in the expected reduction of BrdU-positive cells when cells were transfected with a control small interfering (siRNA) (siCon). However, siRNA-induced depletion of the cyclin-dependent kinase inhibitor, p21 (sip21; Figure 1b ), alleviated the block in cell cycle progression observed when miR-17 or miR-20a was inhibited to levels similar to untransfected (10%) or 2 0 oMe-Luctransfected cells (Figure 1b) . We also examined the potential contribution of the p53 transcription factor and the DNA damage sensing and checkpoint signaling protein, 53BP1, to the block in cell cycle progression initiated by miR-17 or miR-20a inhibition. Similar to depleting p21, transfecting sip53 or si53BP1 (Figure 1c ) increased the percentage of cells entering S phase when miR-17 or miR-20a was inhibited (Figure 1c) . Because of the large molecular weight of 53BP1, an actin loading control was not feasible. For this reason, transfected cells were also immunostained for 53BP1 (Supplementary Figure 1 ). Taken together, these results suggest that miR-17 and miR-20a govern G1 cell cycle progression, and that disrupting this regulation leads to activation of a G1 checkpoint involving p21, p53 and 53BP1.
Data have shown that disrupting the control of oncoproteins involved in regulating G1 progression can lead to a cell cycle checkpoint (Dimri et al., 2000; Lomazzi et al., 2002; Frame et al., 2006) due to an accumulation of DNA double-strand breaks (DSBs) (Bartkova et al., 2005; Pickering and Kowalik, 2006) . Hallmarks of DNA damage are the phosphorylation of the H2AX histone protein, termed gH2AX (Rogakou et al., 1998) , and localization of gH2AX adjacent to sites of DNA breaks, which can be visualized as discrete foci by immunostaining (Rogakou et al., 1999) . We initially determined whether inhibition of miR-17 or miR-20a resulted in gH2AX foci formation in cycling cells. Transfecting 2 0 oMe-miR17 or 2 0 oMe-miR20a into cycling cells resulted in a four-to fivefold increase in the number of cells containing gH2AX foci (Figures 2a  and b) . To determine whether gH2AX foci formation correlated with the reduction in BrdU incorporation, cells were treated as shown in Figure 1a , and then immunostained for markers of DNA damage. Similar to what was observed in cycling cells, the percentage of cells containing gH2AX foci was higher during the duration of serum stimulation when miR-17 or miR-20a was inhibited (Figure 2c ). Given that 53BP1 localizes at DSB sites (Schultz et al., 2000) and that we found a role for it in the G1 checkpoint associated with inhibiting miR-17 or miR-20a, we examined 53BP1 foci formation following miRNA inhibition. The percentage of cells containing 53BP1 foci increased following serum and BrdU addition when miR-17 or miR-20a was inhibited (Figure 2d; Supplementary Figure 1) . We then asked whether inhibiting the miRNAs leads to DSB accumulation by neutral comet assay, a direct measure of DSBs (Olive et al., 1991 (Olive et al., , 1992 . Indeed, an B3-fold increase in DSB-positive cells was observed following inhibition of miR-17 or miR-20a (Figure 2e ). To determine whether progression into S phase was required to generate the DDR when the miRNAs were inhibited, we treated cells as shown in Figure 1a and then co-immunostained cells for gH2AX and BrdU. Of the gH2AX foci containing cells, the majority (75.0% for 2 0 oMe-miR17; 72.4% for 2 0 oMe-miR20a) did not costain with BrdU ( Figure 2f and Supplementary Figure 2) . As expected, untransfected or 2 0 oMe-Luc-transfected cells, had low levels of gH2AX foci, and most (84.6% for 10%; 73.3% for Luc) of these gH2AX foci containing cells costained with BrdU. Taken together, these data show that inhibiting miR-17 or miR-20a results in a DDR that correlates with the activation of a G1 checkpoint.
One of the demonstrated targets of miR-17 and miR20a is the E2F1 transcript (O'Donnell et al., 2005) (Figure 3a) . Given that E2F1 protein is expressed late in G1 despite E2F1 mRNA accumulation earlier in G1 (O'Donnell et al., 2005), we asked whether miR-17 and miR-20a regulate the precise timing of E2F1 expression as cells progress through R. The temporal accumulation of E2F1 levels was examined in extracts from serumstimulated fibroblasts. In untransfected or 2 0 oMe-Luctransfected cells (Figure 3b ), E2F1 accumulation peaked 15-18 h following serum stimulation. However, inhibiting miR-17 or miR-20a resulted in earlier (9-12 h) E2F1 accumulation, following serum stimulation (Figure 3b) . Despite the temporal shift in E2F1 accumulation, E2F1 levels were not appreciably higher when miR-17 or miR20a was inhibited compared to 2 0 oMe-Luc-transfected control cells (Figure 3b) . However, the timing of E2F1 accumulation suggests that it may play a role in the DDR and G1 checkpoint associated with inhibiting miR-17 or miR-20a.
Overexpression data from our laboratory and others have shown that E2F1 deregulation leads to a DDR (Powers et al., 2004; Rogoff et al., 2004; Bartkova et al., 2005; Pickering and Kowalik, 2006; Hong et al., 2008) and G1 checkpoint (Lomazzi et al., 2002; Frame et al., 2006) . Therefore, we asked whether the DDR and G1 checkpoint that we observed following inhibition of miR-17 or miR-20a were due to deregulation of physiological levels of E2F1. To assess whether E2F1 was involved in signaling a DDR and G1 checkpoint following miR-17 or miR-20a inhibition, the percentage of gH2AX-or BrdU-positive cells was determined in cells depleted for E2F family members (Figure 3c ). Although the E2F family consists of eight genes, we focused on E2F1, E2F2 and E2F3a because collectively they mediate the G1 to S transition (Dimova and Dyson, 2005) and because miR-17 and miR-20a regulate their protein levels (O'Donnell et al., 2005; Sylvestre et al., 2007) . Depleting E2F2 or E2F3a did not reduce gH2AX foci formation following inhibition of miR-17 miR17 and miR20a prevent E2F1-induced G1 arrest MT Pickering et al or miR-20a beyond controls (Figure 3d ). However, depleting E2F1 diminished the percentage of gH2AX-positive cells resulting from miR-17 or miR-20a inhibition to levels in untransfected or 2 0 oMe-Luc-transfected controls (Figure 3d ). Depleting E2F1 also alleviated the G1 checkpoint associated with inhibiting miR-17 or miR-20a, whereas depleting E2F2 or E2F3a had little effect (Figure 3e ), despite the increase in E2F2 and E2F3a levels (Sylvestre et al., 2007) (Figure 3c ). These data implicate these miRNAs in delaying the accumulation of E2F1 to prevent an E2F1-associated DDR that leads to a G1 arrest.
Here, we show that temporal regulation of cell cycle progression is exerted by two miRNAs, miR-17 and miR-20a. Disrupting miR-17 or miR-20a during G1 progression resulted in premature E2F1 accumulation, leading to a DNA damage-induced G1 checkpoint. These miRNAs maintain low E2F1 protein levels through G1, until increased E2F1 levels are tolerated by the cell at the G1/S boundary. It will be interesting to determine what environmental change(s) occurs during the temporal progression from G1 to S that allows cells to tolerate increased E2F1 levels. Our results are consistent with recent data indicating that E2F activation is 'all-or-none' through R (Yao et al., 2008) and suggests a miRNA-mediated mechanism as a regulator of this activation. We and others have previously shown that marked changes in E2F1 levels by overexpression or Rb inactivation leads to a DDR (Powers et al., 2004; Rogoff et al., 2004; Bartkova et al., 2005; Pickering and Kowalik, 2006) and subsequent G1 arrest (Lomazzi et al., 2002; Frame et al., 2006) . Interestingly, inactivation of the miRNAs in random cycling cells led to only a B2-fold induction in E2F1 (Figure 3a ), but this inappropriately timed increase in E2F1 was sufficient to induce a DDR-induced checkpoint (Figures 2a, b Figure 2 Inhibition of miR-17 or miR-20a leads to a DNA damage response. (a) Cycling fibroblasts were transfected with 2 0 oMemiR17, 2 0 oMe-miR20a or 2 0 oMe-Luc and immunostained for gH2AX foci . (b) Quantification of (a). (c-f) Cells were treated as in Figure 1a and the percentage of cells positive for gH2AX foci (c) 53BP1 foci (Frame et al., 2006; Pickering and Kowalik, 2006 ) (d) neutral comet assay tail formation (e) miR17 and miR20a prevent E2F1-induced G1 arrest MT Pickering et al and e). Given that E2F1 levels accumulate during normal progression into S (Figure 3b ) and that inhibition of the miRNAs did not lead to gross changes in E2F1 levels, but rather, disrupted the timing of E2F1 accumulation, we suggest that the strict timing of E2F1 accumulation may serve as a sensitive gauge for a cellular alarm system, alerting the cell to potentially oncogenic changes that culminate in E2F1 accumulation at a prohibited time.
It remains to be determined what the long-term consequence(s) of inhibiting these miRNAs is to an untransformed cell. Data have suggested that inhibiting the miRNAs in cancer cells results in apoptosis (He et al., 2005; Matsubara et al., 2007; Sylvestre et al., 2007) . Another possibility is that long-term inhibition of these miRNAs in normal cells with intact checkpoint functions may prolong G1 arrest, and could lead to senescence, given that E2F1 overexpression can generate this phenotype (Dimri et al., 2000) .
Consistent with the idea that there are multiple levels of regulation during cell cycle transitions, a recent study shows that a related miRNA, miR-106b, promotes G1 exit by directly downregulating the p21 cyclin-dependent kinase inhibitor (Ivanovska et al., 2008) . In addition, E2F1 and E2F3 contribute to the regulation of the miR-17-92 cluster (Woods et al., 2007) , although this likely occurs following R, when E2F1 and E2F3 are transcriptionally active. These observations, together with our results, highlight the importance of stringently regulating G1 progression on (at least) three different levels and raise the possibility that miRNAs may regulate other cell cycle transitions. Our findings fit the emerging concept that miRNAs 'fine-tune' gene expression to precisely regulate the temporal expression of target genes and provide a novel mechanism whereby miRNAs contribute to a cellular alarm system, consisting of a DDR and G1 checkpoint, that becomes activated upon errant timing of oncoprotein expression. 
